But it isn’t pot or cannabis oil. It’s a prescribed pharmaceutical that isn’t as ubiquitous as over-the-counter acetaminophen , which also sends kids to emergency rooms. It’s called buprenorphine , that was originally authorized as a painkiller up to 50 times stronger than morphine, according to the Washington, DC-based Fox 5 information site. After that, buprenorphine was blended with naloxone, utilized as an antidote for opioid medication overdoses, including heroine and OxyContin. The mix of both of these drugs was designed to ween junkies and prescription painkiller users from addiction through withdrawal to completely clean again with much less cravings and suffering and little if any high sensation.AusBiotech highly encourages the Australian Parliament to aid the Bill so the many consequential great things about the law reform could be effected. Having finished enrollment of a 150-patient randomized Phase 2 study in advanced non-little cell lung cancer, Cerulean is starting to capitalize on the breadth of the CRLX101 opportunity by expanding its advancement into extra tumor types with many studies carried out by leading investigators.D. Related StoriesJumping genes: a marker for early cancer diagnosis? An interview with Dr Matt Silver We have observed that the unique intratumor pharmacokinetic properties of our nanopharmaceuticals can lead to novel pharmacodynamic results, said Edward Garmey, M.D., chief medical officer of Cerulean.